research use only

Voclosporin phosphatase inhibitor

Cat.No.E1027

Voclosporin is a potent, inhibitor of Calcineurin. It exhibits both immunomodulatory and non-immune effects by inhibiting T-cell proliferation, reducing proteinuria through podocyte cytoskeleton stabilization and afferent arteriole vasoconstriction, and effectively suppressing lymphocyte proliferation and cytokine production, making it useful for systemic lupus erythematosus (SLE) research.
Jump to

Quality Control

Batch: E102701 DMSO]100 mg/mL]false]Ethanol]100 mg/mL]false]Water]Insoluble]false Purity: 98.43%
98.43

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (82.33 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 1214.62 Formula

C63H111N11O12

Storage (From the date of receipt)
CAS No. 515814-01-4 Download SDF Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-08-12)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07760480 RECRUITING
Lupus Nephritis; Systemic Lupus Erythematosus (SLE)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2026-04-23 PHASE4
NCT06406205 RECRUITING
Lupus Nephritis
Qilu Pharmaceutical Co., Ltd.
2023-12-25 PHASE3
NCT07225387 RECRUITING
Lupus Nephritis
NephroNet, Inc.
2024-10-01 PHASE4
NCT05962788 TERMINATED
Adolescent Lupus Nephritis; Pediatric Lupus Nephritis
Aurinia Pharmaceuticals Inc.
2024-03-28 PHASE3
NCT05288855 TERMINATED
Adolescent Lupus Nephritis; Pediatric Lupus Nephritis
Aurinia Pharmaceuticals Inc.
2023-10-10 PHASE3
NCT05306873 TERMINATED
Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)
2022-11-30 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.